Caption
: Recruiting trial
= 
; Ongoing trial
= 
-
- FRANCE
- ILE DE FRANCE
- PARIS
- Phase II/III, Multicenter, Randomized, Parallel Group, Double-Blind, Placebo Controlled Study to Assess Safety and Efficacy of TRO19622 in Amyotrophic Lateral Sclerosis (ALS) Patients Treated With Riluzole (MITOTARGET)
- CHU Hôpital Pitié-Salpêtrière
- Fédération des maladies du système nerveux
- More details
-
- FRANCE
- ILE DE FRANCE
- PARIS
- Evaluation of a Mechanical Insufflation-exsufflation Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders: a Prospective, Randomized, Controlled, Multicenter Study (Phase III)
- CHU Hôpital d'Enfants Armand-Trousseau
- Service de pneumologie pédiatrique
- More details
-
- FRANCE
- ILE DE FRANCE
- PARIS
- LISLA : A Phase II Open Multicenter Study of Lithium in Patients With Amyotrophic Lateral Sclerosis
- Hôpital Saint-Louis
- Département à la Recherche Clinique et Développement
- More details
-
- GERMANY
- Baden-Württemberg
- ULM
- Phase II Study of pioglitazone in patients with amyotrophic lateral sclerosis
- Universitätsklinikum Ulm
- Klinik für Neurologie
- More details
-
- MITOTARGET : Mitochondrial dysfunction in neurodegenerative diseases: towards new therapeutics (Phase II-III)
- Charité - Universitätsmedizin Berlin (CVK)
- Poliklinik für Neurologie am Campus Charité Virchow
- More details
-
- GERMANY
- Nordrhein-Westfalen
- MÜNSTER
- Influence of G-CSF(granulocyte colony-stimulating factor) and EPO(Erythropoietin) on associative learning and motor skills (Phase II)
- Universitätsklinikum Münster
- Klinik und Poliklinik für Neurologie
- More details
-
- Efficacy safety and tolerability of growth hormone n patients with amyotrophic lateral sclerosis as add-on therapy to Riluzole-Phase II
- Università degli Studi di Napoli "Federico II"
- Dipartimento di Scienze Neurologiche
- More details
-
- NETHERLANDS
- Utrecht
- UTRECHT
- Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis
- UMC Utrecht - Universitair Medisch Centrum Utrecht
- Sectie Neuromusculaire Aandoeningen
- More details
-
- NETHERLANDS
- Utrecht
- UTRECHT
- LITRA study: the effect of lithium on survival in patients with ALS - a randomised double-blind sequential trail
- UMC Utrecht - Universitair Medisch Centrum Utrecht
- Afdeling Neurologie
- More details
-
- Memantine for Disability in Amyotrophic Lateral Sclerosis (Phase II-III) - Terminated -
- Hospital de Sta. Maria
- Faculdade de Medicina de Lisboa
- More details
-
- A Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Tolerability and Safety of Talampanel in Subjects With Amyotrophic Lateral Sclerosis (ALS) (Phase II)
- Hospital Carlos III
- Unidad de ELA (Esclerosis Lateral Amiotrófica)
- More details
-
- Phase II/III, Multicenter, Randomized, Parallel Group, Double-blind, Placebo Controlled Study to Assess Safety and Efficacy of TRO19622 in Amyotrophic Lateral Sclerosis (ALS) Patients Treated With Riluzole (MITOTARGET)
- Hospital Carlos III
- Unidad de ELA (Esclerosis Lateral Amiotrófica)
- More details
-
- Randomized clinical trial double blind of litium carbonate as association therapy in amyotrophic lateral sclerosis (Phase II)
- Hospital Universitario 12 de Octubre
- Unidad de ELA (Esclerosis Lateral Amiotrófica)
- More details
-
- Phase I/II Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis
- Hospital Universitario Virgen de la Arrixaca
- Unidad de trasplante hematopoyético y terapia celular
- More details
